
EZZ Life Science Holdings Limited
ASX:EZZ.AX
2.42 (AUD) • At close July 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2019 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||
Current Assets: | |||||||||||
Cash & Cash Equivalents
| 19.891 | 19.023 | 12.618 | 10.465 | 9.586 | 10.465 | 8.946 | 8.854 | 3.81 | 3.175 | 0.414 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 19.891 | 19.023 | 12.618 | 10.465 | 9.586 | 10.465 | 8.946 | 8.854 | 3.81 | 3.175 | 0.414 |
Net Receivables
| 2.686 | 2.674 | 3.277 | 1.317 | 3.231 | 2.294 | 1.533 | 2.189 | 1.473 | 2.535 | 2.41 |
Inventory
| 1.539 | 1.401 | 1.559 | 0.312 | 0.731 | 0.312 | 0.495 | 0.272 | 0.386 | 0.033 | 0 |
Other Current Assets
| 4.492 | 1.814 | 2.137 | 1.011 | 1.186 | 0.902 | 0.515 | 0.42 | 0.388 | 0.341 | -0 |
Total Current Assets
| 28.608 | 24.912 | 19.591 | 13.973 | 14.733 | 13.973 | 11.488 | 11.734 | 6.057 | 6.083 | 2.824 |
Non-Current Assets: | |||||||||||
Property, Plant & Equipment, Net
| 1.114 | 0.622 | 0.633 | 0.149 | 0.092 | 0.149 | 0.073 | 0.132 | 0.187 | 0.097 | 0.089 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.02 | 0.019 | 0.019 | 0.019 | 0.019 | 0.019 | 0.019 | 0.011 | 0.01 | 0.001 | 0.001 |
Goodwill and Intangible Assets
| 0.02 | 0.019 | 0.019 | 0.019 | 0.019 | 0.019 | 0.019 | 0.011 | 0.01 | 0.001 | 0.001 |
Long Term Investments
| 0 | 0 | -0.053 | 0.623 | 0.111 | 0.168 | 0.092 | 0.135 | 0.188 | 0.088 | 0.088 |
Tax Assets
| 0 | 0 | 0.053 | 0.125 | 0.133 | 0.125 | 0.177 | 0.162 | 0.07 | 0.004 | 0.001 |
Other Non-Current Assets
| 0 | 0 | 0.053 | -0.623 | -0.111 | -0.168 | -0.092 | -0.135 | -0.188 | -0.088 | -0.089 |
Total Non-Current Assets
| 1.134 | 0.64 | 0.706 | 0.293 | 0.245 | 0.293 | 0.269 | 0.305 | 0.267 | 0.102 | 0.09 |
Total Assets
| 29.742 | 25.552 | 20.297 | 14.265 | 14.978 | 14.265 | 11.757 | 12.039 | 6.324 | 6.185 | 2.915 |
Liabilities & Equity: | |||||||||||
Current Liabilities: | |||||||||||
Account Payables
| 4.245 | 2.733 | 2.8 | 1.541 | 0.464 | 0.728 | 1.386 | 0.473 | 0.426 | 3.19 | 1.24 |
Short Term Debt
| 0.355 | 0.124 | 0.304 | 0.355 | 0.053 | 0.105 | 0.027 | 0.079 | 0.13 | 0.032 | 0 |
Tax Payables
| 0 | 1.157 | 0.219 | 0.293 | 0.226 | 0.243 | 0.07 | 0.18 | 0.987 | 0.529 | 0.355 |
Deferred Revenue
| 0 | 0 | 0.219 | 0 | 0.226 | 0.243 | 0.07 | 0.18 | 0.987 | 0.529 | 0 |
Other Current Liabilities
| 0.733 | 0.164 | 1.458 | 0.746 | 1.352 | 1.741 | 0.15 | 1.017 | 0.161 | -0.504 | 0.496 |
Total Current Liabilities
| 5.333 | 4.178 | 4.999 | 2.817 | 2.32 | 2.817 | 1.704 | 1.93 | 2.691 | 3.775 | 2.091 |
Non-Current Liabilities: | |||||||||||
Long Term Debt
| 0.124 | 0 | 0 | 0.124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0.051 | 0 | 0.061 | 0.029 | 0.061 | 0.013 | 0.001 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.247 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0.371 | 0.051 | 0 | 0.061 | 0.029 | 0.061 | 0.013 | 0.001 | 0 | 0 | 0 |
Total Liabilities
| 5.704 | 4.229 | 4.999 | 2.878 | 2.349 | 2.878 | 1.716 | 1.931 | 2.691 | 3.775 | 2.091 |
Equity: | |||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 7.295 | 6.853 | 5.999 | 5.823 | 5.667 | 5.823 | 5.667 | 5.667 | 0 | 0 | 0 |
Retained Earnings
| 16.729 | 14.454 | 9.298 | 5.564 | 6.671 | 5.564 | 4.351 | 4.441 | 3.633 | 2.41 | 0.824 |
Accumulated Other Comprehensive Income/Loss
| 0.014 | 0.016 | 0.001 | 0.001 | 0.29 | 0 | 0.022 | 0 | -0 | 0 | 0 |
Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Equity
| 24.038 | 21.323 | 15.298 | 11.387 | 12.628 | 11.387 | 10.041 | 10.108 | 3.633 | 2.41 | 0.824 |
Total Equity
| 24.038 | 21.323 | 15.298 | 11.387 | 12.628 | 11.387 | 10.041 | 10.108 | 3.633 | 2.41 | 0.824 |
Total Liabilities & Shareholders Equity
| 29.742 | 25.552 | 20.297 | 14.265 | 14.978 | 14.265 | 11.757 | 12.039 | 6.324 | 6.185 | 2.915 |